These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8761791)

  • 21. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common drug reactions: their mechanisms and management.
    Blaylock WK
    Va Med; 1981 Aug; 108(8):529-33. PubMed ID: 6457456
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on insulin pump therapy.
    Marschilok C
    School Nurse News; 2007 Jan; 24(1):12-3. PubMed ID: 17283701
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin pump therapy.
    Rowe R
    Diabet Med; 2001 Nov; 18 Suppl 4():4-5. PubMed ID: 11989214
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's your assessment? Dermatitis medicamentosa.
    Bielan B
    Dermatol Nurs; 2001 Jun; 13(3):227-8. PubMed ID: 11917459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin pump therapy. An overview.
    Miller MM
    Adv Nurse Pract; 2003 Nov; 11(11):61-3, 66. PubMed ID: 14639884
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous reactions to anticonvulsants.
    Chang DK; Shear NH
    Semin Neurol; 1992 Dec; 12(4):329-37. PubMed ID: 1485042
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse cutaneous reactions to drugs: an overview.
    Sharma VK; Sethuraman G
    J Postgrad Med; 1996; 42(1):15-22. PubMed ID: 9715291
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of diabetes with the insulin pump].
    Koznarová R; Jirkovská A; Pelikánová T
    Cas Lek Cesk; 2001 Apr; 140(8):227-9. PubMed ID: 11392038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug hypersensitivity, 3. Pathomechanism and treatment of severe cutaneous drug reactions].
    Ikezawa Z
    Arerugi; 2007 Oct; 56(10):1231-9. PubMed ID: 17982283
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous reactions associated with alpha interferon therapy.
    Stafford-Fox V; Guindon KM
    Clin J Oncol Nurs; 2000; 4(4):164-8. PubMed ID: 11261097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin therapy in children and adolescents with Type 1 diabetes.
    McAssey K; Perlman K; Daneman D
    Diabetes Nutr Metab; 1999 Apr; 12(2):86-95. PubMed ID: 10554891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-threatening autoimmunity with diabetes: management with an insulin pump.
    Franklin VL; Torrance T; Peebles M; Wilkie R; Greene S
    Pediatr Diabetes; 2003 Sep; 4(3):151-4. PubMed ID: 14655274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events.
    Scaramuzza A; Iafusco D; Lombardo F; Rabbone I; Toni S;
    Pediatrics; 2008 Aug; 122(2):473-4; author reply 474. PubMed ID: 18676571
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment.
    Brunton S
    Am J Med; 2008 Jun; 121(6 Suppl):S35-41. PubMed ID: 18514089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.
    Shalitin S; Phillip M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: a comparison with multiple daily insulin injections.
    Bin-Abbas B; Al-Ashwal A; Sakati N
    Ann Saudi Med; 2006; 26(4):327-8. PubMed ID: 16891848
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.